dapsone has been researched along with P carinii Infection in 22 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of P carinii infection presenting as bilateral aural polyps, otitis media and mastoiditis in human immunodeficiency (HIV)-positive patient with no history of prior or concomitant P carinii infection." | 2.41 | Pneumocystis carinii infection in bilateral aural polyps in a human immunodeficiency virus-positive patient. ( Elmahallawy, M; Horsfield, C; Praveen, CV; Terry, RM, 2002) |
| "Dapsone was discontinued with resolution of all symptoms." | 1.35 | Didactic lessons from the serum lactate dehydrogenase posttransplant: a clinical vignette. ( Boothpur, R; Brennan, DC, 2008) |
| " Extending these experiments, we have now shown that roxithromycin at doses of 400 or 200 mg/kg/day combined with dapsone at doses of 5, 25 or 50 mg/kg/day completely prevented the development of T." | 1.30 | Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model. ( Brun-Pascaud, M; Chau, F; Derouin, F; Girard, PM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (54.55) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mack, J | 1 |
| Mian, A | 1 |
| Roxby, A | 1 |
| Jain, R | 1 |
| Kumar, MS | 1 |
| Sierka, DR | 1 |
| Damask, AM | 1 |
| Fyfe, B | 1 |
| McAlack, RF | 1 |
| Heifets, M | 1 |
| Moritz, MJ | 1 |
| Alvarez, D | 1 |
| Kumar, A | 1 |
| Sangiolo, D | 1 |
| Storer, B | 1 |
| Nash, R | 1 |
| Corey, L | 1 |
| Davis, C | 1 |
| Flowers, M | 1 |
| Hackman, RC | 1 |
| Boeckh, M | 1 |
| Talarico, JF | 1 |
| Metro, DG | 1 |
| Dunford, LM | 1 |
| Roy, DM | 1 |
| Hahn, TE | 1 |
| Padmanabhan, S | 1 |
| Segal, BH | 1 |
| Almyroudis, N | 1 |
| McCarthy, PL | 1 |
| Battiwalla, M | 1 |
| Boothpur, R | 1 |
| Brennan, DC | 1 |
| Mahlakwane, MS | 1 |
| Ramdial, PK | 1 |
| Sing, Y | 1 |
| Calonje, E | 1 |
| Biyana, S | 1 |
| Mehlhorn, H | 1 |
| Dankert, W | 1 |
| Hartman, PG | 1 |
| Then, RL | 1 |
| Hughes, WT | 1 |
| Killmar, JT | 1 |
| Oz, HS | 1 |
| Brun-Pascaud, M | 3 |
| Chau, F | 3 |
| Simonpoli, AM | 1 |
| Girard, PM | 3 |
| Derouin, F | 3 |
| Pocidalo, JJ | 1 |
| Podzamczer, D | 1 |
| Martos, A | 1 |
| Ferrer, I | 1 |
| Santin, M | 1 |
| Gudiol, F | 1 |
| Garry, L | 1 |
| Jacobus, D | 1 |
| Bundow, DL | 1 |
| Aboulafia, DM | 1 |
| Ruggli, GM | 1 |
| Weber, R | 1 |
| Messmer, EP | 1 |
| Font, RL | 1 |
| Moll, C | 1 |
| Bernauer, W | 1 |
| Fishman, JA | 1 |
| Ioannidis, JP | 1 |
| Dixon, DO | 1 |
| McIntosh, M | 1 |
| Albert, JM | 1 |
| Bozzette, SA | 1 |
| Schnittman, SM | 1 |
| Patel, SK | 1 |
| Philpott, JM | 1 |
| McPartlin, DW | 1 |
| Vasconcelles, MJ | 1 |
| Bernardo, MV | 1 |
| King, C | 1 |
| Weller, EA | 1 |
| Antin, JH | 1 |
| Praveen, CV | 1 |
| Terry, RM | 1 |
| Elmahallawy, M | 1 |
| Horsfield, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Trial of Three Anti-Pneumocystis Agents Plus Zidovudine for the Primary Prevention of Serious Infections in Patients With Advanced HIV Infection[NCT00000991] | Phase 3 | 600 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for dapsone and P carinii Infection
| Article | Year |
|---|---|
Skin involvement with Pneumocystis despite dapsone prophylaxis: a rare cause of skin nodules in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Dermatomycoses; Humans | 1997 |
Treatment of infection due to Pneumocystis carinii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Atovaquone; Clindamycin; Dapsone; Eflornithine; Humans | 1998 |
An unusual case of Pneumocystis carinii presenting as an aural mass.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Drug Therapy, Combinat | 1999 |
Pneumocystis carinii infection in bilateral aural polyps in a human immunodeficiency virus-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Dapsone; Ear Neoplasms; Ear, Middle | 2002 |
1 trial available for dapsone and P carinii Infection
| Article | Year |
|---|---|
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Antifungal Agents; Bone Ma | 2000 |
17 other studies available for dapsone and P carinii Infection
| Article | Year |
|---|---|
Case 5: Fever and Hypoxia in a 17-year-old Boy Undergoing Cancer Chemotherapy.
Topics: Adolescent; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Dapsone; Fever; H | 2017 |
Dapsone interferes with hemoglobin A1c monitoring of diabetes in an HIV-infected patient.
Topics: Blood Glucose; Burkitt Lymphoma; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Dapsone | 2013 |
Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.
Topics: AIDS-Associated Nephropathy; Candidiasis, Oral; Dapsone; Female; Graft Rejection; HIV Seropositivity | 2005 |
Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Case-Control Studies; Child; Child, Preschool; Dapso | 2005 |
Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant.
Topics: Adolescent; Anesthesia, General; Anti-Infective Agents; Dapsone; Folic Acid Antagonists; Humans; Int | 2005 |
Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.
Topics: Adult; Anemia, Aplastic; Anti-Infective Agents; Dapsone; Female; Hematopoietic Stem Cell Transplanta | 2006 |
Didactic lessons from the serum lactate dehydrogenase posttransplant: a clinical vignette.
Topics: Anti-Infective Agents; Biomarkers; Dapsone; Female; Humans; Kidney Transplantation; L-Lactate Dehydr | 2008 |
Otic pneumocystosis in acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Drug Therapy, Combinat | 2008 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Female; F | 1995 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Tria | 1994 |
Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Brain; Dapsone; Drug Therapy, Combinat | 1994 |
Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Humans; Liver Dise | 1993 |
Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid | 1996 |
Pneumocystis carinii infection of the conjunctiva in a patient with acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Conjunctiva; Conjunctival Disea | 1997 |
Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Disease Models, Animal; Dose-Respons | 1998 |
Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Controlled Clinical Trials as Topic; D | 1999 |